Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 4.13 GBp
Change Today -0.125 / -2.94%
Volume 1.0M
As of 11:30 AM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

plethora solutions holdings (PLE) Snapshot

Open
4.25 GBp
Previous Close
4.25 GBp
Day High
4.25 GBp
Day Low
4.13 GBp
52 Week High
06/3/14 - 13.38 GBp
52 Week Low
03/30/15 - 3.38 GBp
Market Cap
28.1M
Average Volume 10 Days
1.0M
EPS TTM
-0.03 GBp
Shares Outstanding
681.0M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for PLETHORA SOLUTIONS HOLDINGS (PLE)

Related News

No related news articles were found.

plethora solutions holdings (PLE) Related Businessweek News

No Related Businessweek News Found

plethora solutions holdings (PLE) Details

Plethora Solutions Holdings plc engages in the development and commercialization of pharmaceutical products for the treatment of premature ejaculation in the area of men’s sexual health in the United Kingdom. Its products include PSD502, a topical spray for the treatment of premature ejaculation. The company was founded in 2004 and is headquartered in Chalgrove, the United Kingdom.

5 Employees
Last Reported Date: 03/30/15
Founded in 2004

plethora solutions holdings (PLE) Top Compensated Officers

Co-Founder, Chief Technical Officer, Chief Sc...
Total Annual Compensation: 137.0K GBP
Chief Financial Officer, Director and Member ...
Total Annual Compensation: 29.0K GBP
Compensation as of Fiscal Year 2013.

plethora solutions holdings (PLE) Key Developments

Plethora Solutions Holdings PLC Announces Management Changes

Plethora Solutions Holdings PLC announced that Mr. Anthony Baillieu has been appointed to the Board as a Non-Executive Director with immediate effect and Mike Collis, Chief Financial Officer, will leave the Board on May 31, 2015 to pursue other opportunities. Colin Kunz has been appointed as Chief Financial Officer to the Company but will not fulfil a Board position. Mike Collis will work with Colin to effect an orderly handover and will continue to work with the Company on a consultancy basis from 1 June 2015. In the past 7 years Colin has served as Finance Director to Rhead Group, Benson Group and Mediwatch plc (a formerly AIM quoted company).

Plethora Solutions Holdings plc Reports Audited Consolidated Earnings Results for the Year Ended December 31, 2014

Plethora Solutions Holdings PLC reported audited consolidated earnings results for the year ended December 31, 2014. For the period, the company’s operating loss was £16,206,000 against £2,898,000 a year ago. Loss from continuing operations for the year before tax was £15,734,000 against £8,755,000 a year ago. Loss for the year and total comprehensive loss attributable to the owners of the parent was £15,691,000 against £8,500,000 a year ago. Basic and diluted loss per share from total and continuing operations was 3.2 pence against 2.6 pence a year ago. Net cash outflow from operating activities was £15,475,000 against £3,137,000 a year ago. Purchase of property, plant and equipment was £82,000.

Plethora Solutions Holdings PLC Auditor Raises 'Going Concern' Doubt

Plethora Solutions Holdings PLC filed its Annual on Mar 30, 2015 for the period ending Dec 31, 2014. In this report its auditor, PricewaterhouseCoopers LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PLE:LN 4.13 GBp -0.125

PLE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Tribute Pharmaceuticals Canada Inc C$1.23 CAD +0.10
View Industry Companies
 

Industry Analysis

PLE

Industry Average

Valuation PLE Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 6.1x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 8.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PLETHORA SOLUTIONS HOLDINGS, please visit www.plethorasolutions.co.uk. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.